Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Immunogenomics Market Size Forecast: How Large Could The Market Become By 2030?
The landscape of immunogenomics has experienced substantial recent expansion, with projections indicating a surge from $6.09 billion in 2025 to $7.07 billion by 2026, reflecting a compound annual growth rate of 16.1%. This period of robust growth is underpinned by key factors including leaps in genomic sequencing capabilities, a deepening comprehension of genetic influences on the immune system, the broadening scope of research in oncology and infectious diseases, elevated levels of research investment, and the accessibility of advanced genomic analytical tools.
The immunogenomics market is projected for substantial expansion in the upcoming years, anticipating a valuation of $12.73 billion by 2030, propelled by a compound annual growth rate of 15.8%. This upward trajectory is fueled by several key factors, including a heightened demand for precision medicine approaches, the advancement of tailored vaccines and immunotherapies, a broader scope in translational immunogenomics research, the increasing incorporation of multi-omics data, and a greater reliance on cloud-based genomic analytics platforms. Dominant trends shaping this market during the forecast period encompass the escalating utilization of next-generation sequencing for immune profiling, the amplified adoption of bioinformatics tools for dissecting immune-related data, a sharpening focus on the development of individualized immunotherapies, the growth of comprehensive genomic databases dedicated to immune research, and the more profound integration of artificial intelligence within immunogenomic investigations.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28247&type=smp
Immunogenomics Market Growth Drivers And Industry Catalysts
The expanded incidence of contagious ailments is anticipated to be a significant catalyst for the expansion of the immunogenomics sector. Such ailments, caused by detrimental microbes like bacteria, viruses, fungi, or parasites, possess the capacity for transmission between individuals, either directly or indirectly. Globalization and increased mobility contribute to the heightened occurrence of these diseases, allowing pathogens to traverse geographical boundaries with greater ease. Immunogenomics offers a sophisticated approach to managing infectious diseases by facilitating the detailed examination of an individual’s immune reactions and their genetic predispositions. This analytic capability streamlines treatment processes, minimizing guesswork by pinpointing unique immune components for each patient, thereby refining diagnostic precision, accelerating vaccine creation, and fostering the development of tailored treatment plans. Illustrating this trend, data from February 2024, published by the UK Health Security Agency, indicated that tuberculosis diagnoses in England climbed to 4,850 in 2023, marking a 10.7% surge from the 4,380 cases reported in the preceding year. Consequently, the escalating presence of infectious diseases is a key determinant in the advancement of the immunogenomics market.
Immunogenomics Market Segments: Where Are The Largest Growth Opportunities?
The immunogenomics market covered in this report is segmented –
1) By Product Type: Instruments, Consumables, Software, Services
2) By Technology: Next-Generation Sequencing, Microarray, Polymerase Chain Reaction, Other Technologies
3) By Application: Oncology, Infectious Diseases, Autoimmune Disorders, Transplantation, Other Applications
4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Instruments: Sequencers, Microarray scanners, Flow cytometers
2) By Consumables: Reagents, Kits, Assay panels
3) By Software: Data analysis software, Bioinformatics tools, Visualization platforms
4) By Services: Sequencing services, Genomic profiling, Bioinformatics support
#Immunogenomics Market Trends Influencing Long-Term Demand
In the realm of immunogenomics, leading enterprises are dedicated to pioneering sophisticated technologies, including a vaccine target prediction system designed for the automated, comprehensive process of vaccine design. This system enhances vaccine formulations by ensuring the most effective antigen sequences are utilized. Essentially, this computational platform employs bioinformatics algorithms, integrating genomic and immunomic information to pinpoint potential antigen molecules within pathogens or cancerous cells. It further scrutinizes their structural characteristics to rank and choose the most promising vaccine candidates, maximizing their capacity to stimulate robust immune defenses. A prime example is Evaxion Biotech A/S, a Danish firm specializing in AI-powered immunotherapy and vaccine creation, which in September 2024, unveiled its AI-Immunology platform. This clinically validated evolution of their EDEN AI prediction model incorporates a new toxin antigen predictor, significantly boosting the precision and dependability of identifying bacterial toxin antigens for the advancement of next-generation bacterial vaccines. Furthermore, the platform is capable of modeling the human immune system to generate bespoke and advanced immunotherapies, exhibiting a strong congruence between AI-derived predictions and actual clinical results.
Immunogenomics Market Major Participants And Competitive Dynamics
Major companies operating in the immunogenomics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Illumina Inc., BGI Group, GenScript Biotech Corporation, CareDx Inc., Oxford Nanopore Technologies plc, Genewiz LLC, Adaptive Biotechnologies Corporation, GenomOncology LLC, Personalis Inc., Variantyx Inc., CD Genomics Inc., Sengenics Corporation, GeneCentric Therapeutics Inc., Immunogenomics Inc., ImmuQuad Biotechnologies Inc., Neomics Pharmaceuticals LLC, Yemaachi Biotech Ltd., BioAnalytica Biotechnology Systems Inc.
Access The Complete Immunogenomics Market Report:
https://www.thebusinessresearchcompany.com/report/immunogenomics-global-market-report
Immunogenomics Market Regional Distribution: Which Areas Drive Market Expansion?
North Americawas the largest region in the immunogenomics market in 2025. The regions covered in the immunogenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
